Navellier & Associates Inc Decreases Stake in UnitedHealth Group Incorporated (UNH)

Navellier & Associates Inc reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 38.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,994 shares of the healthcare conglomerate’s stock after selling 9,465 shares during the period. Navellier & Associates Inc’s holdings in UnitedHealth Group were worth $2,780,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. BlackRock Inc. increased its position in UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the last quarter. Vanguard Group Inc. increased its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the last quarter. FMR LLC increased its position in UnitedHealth Group by 2.1% during the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the last quarter. Alliancebernstein L.P. increased its position in UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares during the last quarter. Finally, TIAA CREF Investment Management LLC increased its position in UnitedHealth Group by 3.9% during the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after purchasing an additional 223,524 shares during the last quarter. 86.20% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down $3.10 on Friday, hitting $221.25. 2,811,700 shares of the company’s stock were exchanged, compared to its average volume of 3,099,370. UnitedHealth Group Incorporated has a 1-year low of $156.09 and a 1-year high of $231.77. The firm has a market capitalization of $217,410.30, a PE ratio of 23.37, a PEG ratio of 1.67 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same period last year, the business earned $2.17 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. equities analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.26%.

Several equities research analysts recently issued reports on the stock. Leerink Swann restated a “buy” rating and set a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Finally, Wells Fargo & Company restated an “outperform” rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $224.56.

In related news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Insiders sold 12,032 shares of company stock valued at $2,658,310 in the last 90 days. Company insiders own 0.89% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Navellier & Associates Inc Decreases Stake in UnitedHealth Group Incorporated (UNH)” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/15/navellier-associates-inc-decreases-stake-in-unitedhealth-group-incorporated-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply